Published in Infection on March 08, 1999
The prevalence of fluoroquinolone resistance mechanisms in colonizing Escherichia coli isolates recovered from hospitalized patients. Clin Infect Dis (2010) 5.34
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia. Eur J Clin Microbiol Infect Dis (2005) 1.83
Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg Infect Dis (2002) 1.51
Gastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance. Infect Control Hosp Epidemiol (2009) 0.95
Prolonged carriage of resistant E. coli by returned travellers: clonality, risk factors and bacterial characteristics. Eur J Clin Microbiol Infect Dis (2012) 0.91
Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospital. Antimicrob Agents Chemother (2006) 0.83
Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions. Infect Control Hosp Epidemiol (2012) 0.75
Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates. Microb Pathog (1990) 3.18
Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells. Infect Immun (1992) 2.69
Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob Agents Chemother (1998) 2.59
Detection of legionellae in hospital water samples by quantitative real-time LightCycler PCR. Appl Environ Microbiol (2001) 2.43
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother (2000) 2.40
Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ (1999) 2.28
Ochrobactrum anthropi bacteremia: report of four cases and short review. Infection (1994) 2.13
Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J (2008) 1.97
Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants Selected with a fluoroquinolone. Antimicrob Agents Chemother (2001) 1.93
Pulsed field electrophoresis of genomic restriction fragments for the detection of nosocomial Legionella pneumophila in hospital water supplies. J Clin Microbiol (1991) 1.89
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia. Eur J Clin Microbiol Infect Dis (2005) 1.83
Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother (2000) 1.69
Trends in antibiotic use at a university hospital: defined or prescribed daily doses? Patient days or admissions as denominator? Infection (2006) 1.66
CRB-65 predicts death from community-acquired pneumonia. J Intern Med (2006) 1.61
Infection of Acanthamoeba castellanii by Chlamydia pneumoniae. Appl Environ Microbiol (1997) 1.55
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors. Eur Respir J (2009) 1.54
Aggregation substance promotes adherence, phagocytosis, and intracellular survival of Enterococcus faecalis within human macrophages and suppresses respiratory burst. Infect Immun (2000) 1.53
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Ann Hematol (1994) 1.51
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother (1994) 1.49
gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother (1996) 1.48
Staphylococcus saprophyticus urease: characterization and contribution to uropathogenicity in unobstructed urinary tract infection of rats. Infect Immun (1989) 1.47
Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli. J Antimicrob Chemother (1998) 1.47
Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure. Kidney Int (1998) 1.47
Cloning and genetic characterization of the flagellum subunit gene (flaA) of Legionella pneumophila serogroup 1. Infect Immun (1995) 1.47
Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis (2000) 1.47
[New therapeutic strategies for community acquired pneumonia]. Internist (Berl) (2005) 1.43
Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model. Infect Immun (1986) 1.43
Cloning and expression of Staphylococcus saprophyticus urease gene sequences in Staphylococcus carnosus and contribution of the enzyme to virulence. Infect Immun (1989) 1.43
Genome analysis of Legionella ssp. by orthogonal field alternation gel electrophoresis (OFAGE). FEMS Microbiol Lett (1990) 1.39
The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): chemical structure and biological significance. Prog Clin Biol Res (1995) 1.37
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J (2007) 1.34
Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis (2007) 1.31
Overexpresssion of a Legionella pneumophila homologue of the E. coli regulator csrA affects cell size, flagellation, and pigmentation. Int J Med Microbiol (2001) 1.29
Properties of Escherichia coli strains of serotype O6. Infection (1996) 1.26
Reciprocal exchange of minor components of type 1 and F1C fimbriae results in hybrid organelles with changed receptor specificities. J Bacteriol (1994) 1.23
Temperature-dependent expression of flagella in Legionella. J Gen Microbiol (1991) 1.22
Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia. Br J Haematol (2000) 1.20
Characterization of the beta-lactamases of six species of Legionella. J Bacteriol (1982) 1.20
Aggregation substance increases adherence and internalization, but not translocation, of Enterococcus faecalis through different intestinal epithelial cells in vitro. Infect Immun (2000) 1.19
Renal tolerance and pharmacokinetics of vancomycin in rats. J Antimicrob Chemother (1984) 1.17
O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections. Clin Diagn Lab Immunol (1997) 1.17
Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun (1996) 1.17
Moxifloxacin prophylaxis in neutropenic patients. J Antimicrob Chemother (2006) 1.16
Hemagglutinating and adherence properties of Staphylococcus saprophyticus: epidemiology and virulence in experimental urinary tract infection of rats. FEMS Microbiol Immunol (1988) 1.15
Immune depression syndrome following human spinal cord injury (SCI): a pilot study. Neuroscience (2008) 1.14
The structure of the O-specific chain of Legionella pneumophila serogroup 1 lipopolysaccharide. Eur J Biochem (1994) 1.14
Circumcision: the effect of information on parental decision making. Pediatrics (1983) 1.13
Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers. Antimicrob Agents Chemother (1996) 1.12
CAPNETZ-community-acquired pneumonia competence network. Infection (2004) 1.11
[SARS--Severe Acute Respiratory syndrome]. Pneumologie (2003) 1.09
An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection (1998) 1.07
De novo synthesis of Legionella pneumophila antigens during intracellular growth in phagocytic cells. Infect Immun (1996) 1.06
Bacterial colonization and endotoxin contamination of intravenous infusion fluids. J Hosp Infect (1997) 1.06
Differential expression of interleukin-6, intracellular adhesion molecule 1, and major histocompatibility complex class II molecules in renal carcinoma cells stimulated with S fimbriae of uropathogenic Escherichia coli. Infect Immun (1993) 1.04
Cloning, genetic analysis, and nucleotide sequence of a determinant coding for a 19-kilodalton peptidoglycan-associated protein (Ppl) of Legionella pneumophila. Infect Immun (1991) 1.04
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics. Eur Urol (1999) 1.03
Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis (1999) 1.03
Activity of the hypothalamic-pituitary-adrenal axis is altered by aging and exposure to social stress in female rhesus monkeys. J Clin Endocrinol Metab (2000) 1.01
Development and validation of potential structure indicators for evaluating antimicrobial stewardship programmes in European hospitals. Eur J Clin Microbiol Infect Dis (2013) 1.00
Experimental studies on nephrotoxicity and pharmacokinetics of LY 146032 (daptomycin) in rats. J Antimicrob Chemother (1990) 0.99
Antibiotic use in Germany and European comparison. Dtsch Med Wochenschr (2004) 0.99
Diagnosis of ornithosis by cell culture and polymerase chain reaction in a patient with chronic pneumonia. Clin Infect Dis (1995) 0.99
Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection. Infect Immun (1997) 0.99
Mycetoma due to Exophiala jeanselmei and Mycobacterium chelonae in a 73-year-old man with idiopathic CD4+ T lymphocytopenia. Mycoses (1996) 0.99
Use of a receiver operating characteristic in the evaluation of two commercial enzyme immunoassays for detection of Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis (1994) 0.98
Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics. J Antimicrob Chemother (1998) 0.97
[S3-guideline on ambulant acquired pneumonia and deep airway infections]. Pneumologie (2005) 0.97
Comparison of defined versus recommended versus prescribed daily doses for measuring hospital antibiotic consumption. Infection (2009) 0.96
Characterization of coagulase-negative staphylococci causing nosocomial infections in preterm infants. Eur J Clin Microbiol Infect Dis (1995) 0.96
Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product. Clin Exp Immunol (1998) 0.96
Aggregation substance-mediated adherence of Enterococcus faecalis to immobilized extracellular matrix proteins. Microb Pathog (2001) 0.95
Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients. Clin Microbiol Infect (2006) 0.95
Identification and characterization of a surface-associated protein (Ssp) of Staphylococcus saprophyticus. Infect Immun (1992) 0.94
Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity. Infect Immun (2001) 0.94
Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network. Eur J Clin Microbiol Infect Dis (2005) 0.93
A fatal infection with Alternaria alternata and Aspergillus terreus in a child with agranulocytosis of unknown origin. Mycoses (1995) 0.93
Evaluation of a competitive ELISA method for the determination of Klebsiella O antigens. J Med Microbiol (1996) 0.93
Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany. Clin Microbiol Infect (2007) 0.93
Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR. Eur J Clin Microbiol Infect Dis (2003) 0.92
Apnea testing for the determination of brain death: a modified protocol. Technical note. J Neurosurg (1992) 0.92
Identification of 27-oxo-octacosanoic acid and heptacosane-1,27-dioic acid in Legionella pneumophila. FEMS Microbiol Lett (1992) 0.91
Outcomes of invasive infection due to vancomycin-resistant Enterococcus faecium during a recent outbreak. Infection (2009) 0.91
A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. Antimicrob Agents Chemother (1994) 0.91
Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. J Antimicrob Chemother (2009) 0.90
Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients. J Antimicrob Chemother (1993) 0.90
Growth in serum-free medium improves isolation of Chlamydia pneumoniae. J Clin Microbiol (1993) 0.89
From DNA damage to chromosome aberrations: joining the break. Mutat Res (2013) 0.89
Genetics of Escherichia coli uropathogenicity: analysis of the O6:K15:H31 isolate 536. Zentralbl Bakteriol (1992) 0.89